MDMA Statement on GAO Report on Implantable Medical Devices
Wednesday, June 13, 2012
WASHINGTON, DC – Mark Leahey, President and CEO of
the Medical Device Manufacturers Association (MDMA), issued the
following statement today regarding the U.S. Government Accountability
Office’s (GAO) report on implantable medical devices (IMD) and their
impact on health care costs:
"The GAO’s report on IMDs adds to the numerous studies that
demonstrate how medical devices are improving patient care and playing a
pivotal role in driving down costs.
"The GAO’s findings that hospital stays either steadily
dropped or remained the same following procedures to implant medical
devices highlight the impact medical technology has in increasing the
quality of life.
"Medical technology played a pivotal role in decreasing
hospital stays by 56 percent and death rates by 16 percent between 1980
and 2000. This is a remarkable achievement considering medical devices
only represent 6 percent of total health care spending.
"Medical technology innovation continues to lead to fewer
complications, less invasive procedures, and quicker recovery times, all
which save patients and taxpayers money.
"MDMA will continue to work with Members of Congress and
policy makers to share the stories about how medical technology drives
down the costs of health care and improves patient outcomes.”
A copy of the report, "Trends in Beneficiaries Served and Hospital
Resources Used in Implantable Medical Device Procedures,” can be found
by clicking here.